Idelalisib: The First-in-Class Phosphatidylinositol 3-Kinase Inhibitor for Relapsed CLL, SLL, and Indolent NHL.
Hartford Hospital, Hartford, Connecticut.
Nicholas
N
Forcello
Hartford Hospital, Hartford, Connecticut.
Nidhi
N
Saraiya